Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Icu Medical (ICUI) over the last 17 years, with Q1 2025 value amounting to $8.4 million.

  • Icu Medical's Gains from Investment Securities fell 2631.58% to $8.4 million in Q1 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 77748.96%. This contributed to the annual value of -$5.4 million for FY2024, which is 6676.92% up from last year.
  • According to the latest figures from Q1 2025, Icu Medical's Gains from Investment Securities is $8.4 million, which was down 2631.58% from $19.0 million recorded in Q4 2024.
  • In the past 5 years, Icu Medical's Gains from Investment Securities registered a high of $19.0 million during Q4 2024, and its lowest value of -$27.2 million during Q2 2022.
  • For the 5-year period, Icu Medical's Gains from Investment Securities averaged around $460800.0, with its median value being -$339000.0 (2024).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 37625.3% in 2023, then soared by 57617.14% in 2024.
  • Icu Medical's Gains from Investment Securities (Quarter) stood at -$4.9 million in 2021, then skyrocketed by 82.75% to -$838000.0 in 2022, then plummeted by 376.25% to -$4.0 million in 2023, then surged by 576.17% to $19.0 million in 2024, then tumbled by 55.8% to $8.4 million in 2025.
  • Its last three reported values are $8.4 million in Q1 2025, $19.0 million for Q4 2024, and -$3.9 million during Q3 2024.